Autumn Glory Partners
RPRX icon

Autumn Glory Partners’s Royalty Pharma RPRX Stock Holding History

Autumn Glory Partners’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-6,000
Closed -$336K – 213
2026
Q2 		$336K Sell
6,000
-4,000
-40% -$208K 0.1% 165
2026
Q1 		$480K Hold
10,000
– – 0.18% 125
2025
Q4 		$386K Hold
10,000
– – 0.14% 146
2025
Q3 		$353K Hold
10,000
– – 0.14% 139
2025
Q2 		$360K Buy
10,000
+3,000
+43% +$99.4K 0.17% 134
2025
Q1 		$218K Buy
+7,000
New +$222K 0.11% 166

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Autumn Glory Partners's RPRX Position: Q3 2026 in Review

Autumn Glory Partners sold out of Royalty Pharma (RPRX) in Q3 2026, closing a stake of 6,000 shares — an estimated $336K sold.

Autumn Glory Partners first reported a position in RPRX in Q1 2025 and held it in 6 quarters. The position peaked at $480K in Q1 2026. 393 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Autumn Glory Partners reported no remaining Royalty Pharma position as of Q3 2026 after selling out during the quarter.
  • Autumn Glory Partners sold 6,000 Royalty Pharma shares in Q3 2026, an estimated $336K.
  • Autumn Glory Partners first reported a position in Royalty Pharma in Q1 2025 and held it in 6 quarters.
  • Autumn Glory Partners's Royalty Pharma position peaked at $480K in Q1 2026.
  • 393 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Autumn Glory Partners's 13F filing for Q3 2026, filed 26 Oct 2026.